Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout

Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Monomer, MALS verified)

Product Sizes
25 ug
£185.00
HLC-H82E8-25UG
200 ug
£731.00
HLC-H82E8-200UG
About this Product
SKU:
HLC-H82E8
Buffer:
PBS
Conjugate:
Biotin
Extra Details:
The peptide LLDFVRFMGV, derived from the Epstein-Barr virus nuclear antigen EBNA3C, is presented by the HLA-A*02:01/B Beta2m complex. This peptide-MHC complex serves as a major target for cytotoxic T lymphocytes (CTLs) in the immune control of EBV infection. Its robust immunogenicity makes it a key antigen of interest for studying EBV-specific T-cell responses and for developing immunotherapies against EBV-associated diseases.
Immunogen:
HLA-A*0201 & B2M & EBV EBNA3C (LLDFVRFMGV)
Molecular Weight:
36.3 kDa and 13.9 kDa
Physical State:
Powder
Shipping Conditions:
Ambient
Storage Conditions:
-20[o]C
Supplier:
ACRO Biosystems
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.
Immobilized Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Cat. No. HLC-H82E8) at 1 ug/mL (100 uL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 ug/well) plate can bind Anti-HLA class I Antibody, Human IgG1 (W6/32) with a linear range of 0.4-3 ng/mL (QC tested).
Immobilized Biotinylated Human HLA-A*02:01&B2M&EBV EBNA3C (LLDFVRFMGV) Complex Protein (Cat. No. HLC-H82E8) at 1 ug/mL (100 uL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 ug/well) plate can bind Anti-B2M Antibody, Human IgG1 with a linear range of 0.2-2 ng/mL (Routinely tested).